Prime editing method corrects cystic fibrosis in stem cells
A team of scientists used a CRISPR-Cas9 technique known as prime editing to correct cystic fibrosis in cultured human stem cells.
List view / Grid view
A team of scientists used a CRISPR-Cas9 technique known as prime editing to correct cystic fibrosis in cultured human stem cells.
Researchers have used patient-specific tumour organoid models to improve immunotherapy treatments for appendiceal cancer.
Researchers have developed a 3D “assembloid” that presents a potential entry route of COVID-19 into the brain.
To ensure that new drugs are effective and have as little toxicity as possible, they first need to be tested in model systems before entering clinical trials. In this Q&A, Dr Takanori Takebe outlines his research into liver organoids derived from stem cells that can be used to test new…
A team of researchers has shown that injection of cholangiocyte organoids in human livers ex vivo can repair the organs’ bile ducts. In this article, Dr Fotios Sampaziotis explains how his team’s study provides the first proof-of-principle for the efficacy of cellular therapies using organoids in human.
Included in this ebook are articles on stem cell-derived liver organoids and pluripotent cell-derived endothelial cells.
In this ebook, discover how organoids can be used in regenerative medicine and how a novel AAV vector for gene therapy was developed.
Researchers have developed kidney organoids that resemble the collecting duct system, using ureteric bud progenitor cells.
Researchers have developed the first 3D organoid models of the pancreas that includes both the acinar and ductal structures.
Researchers have developed their previously created brain organoid to test for potential drugs against Creutzfeldt-Jakob disease (CJD).
Researchers have shown how different viruses such as HSV-1 and Zika can lead to microcephaly using brain organoids.
Novel organoid models of cervical cancer and a healthy human cervix have been developed to study the condition and its progression.
Induced pluripotent stem cells (iPSC) intestinal organoids have been created to duplicate SARS-CoV-2, enabling drug testing.
Sahm Nasseri discusses promising pre-clinical results of an RNA-based therapeutic developed to treat retinitis pigmentosa type 11.
Thyroid mini-organs have been generated in the lab by researchers, which are able to self-renew and differentiate into functional tissue.